Ginkgo Bioworks Holdings Inc
NYSE:DNA
Cash Flow Statement
Cash Flow Statement
Ginkgo Bioworks Holdings Inc
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(202)
|
(202)
|
(278)
|
(1 837)
|
(2 354)
|
(2 971)
|
(3 538)
|
(2 106)
|
(1 719)
|
(1 221)
|
(854)
|
(893)
|
(854)
|
(898)
|
(651)
|
(547)
|
(472)
|
(315)
|
(340)
|
(313)
|
|
| Depreciation & Amortization |
19
|
20
|
25
|
29
|
32
|
34
|
35
|
43
|
53
|
61
|
73
|
71
|
64
|
64
|
60
|
63
|
66
|
64
|
61
|
59
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
|
| Stock-Based Compensation |
1
|
15
|
15
|
1 606
|
2 259
|
2 851
|
3 414
|
1 931
|
1 351
|
806
|
295
|
230
|
198
|
173
|
135
|
112
|
92
|
77
|
81
|
82
|
|
| Other Non-Cash Items |
21
|
24
|
88
|
1 615
|
2 175
|
2 784
|
3 312
|
1 863
|
1 380
|
855
|
474
|
498
|
467
|
483
|
307
|
255
|
227
|
145
|
132
|
128
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(23)
|
(11)
|
18
|
(62)
|
(79)
|
(138)
|
(121)
|
(37)
|
(22)
|
23
|
(20)
|
30
|
29
|
46
|
(50)
|
(90)
|
(102)
|
(130)
|
(18)
|
(44)
|
|
| Cash from Operating Activities |
(184)
N/A
|
(168)
+9%
|
(148)
+12%
|
(254)
-72%
|
(226)
+11%
|
(290)
-29%
|
(313)
-8%
|
(252)
+19%
|
(323)
-28%
|
(297)
+8%
|
(342)
-15%
|
(296)
+14%
|
(294)
+0%
|
(305)
-4%
|
(335)
-10%
|
(320)
+5%
|
(282)
+12%
|
(238)
+16%
|
(166)
+30%
|
(171)
-3%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(80)
|
(94)
|
(71)
|
(57)
|
(38)
|
(24)
|
(32)
|
(52)
|
(68)
|
(72)
|
(63)
|
(41)
|
(28)
|
(42)
|
(52)
|
(63)
|
(63)
|
(36)
|
(21)
|
(8)
|
|
| Other Items |
(10)
|
(10)
|
(36)
|
(17)
|
(48)
|
(53)
|
(61)
|
(15)
|
17
|
25
|
59
|
(40)
|
(45)
|
(47)
|
(44)
|
0
|
(185)
|
(249)
|
(327)
|
(233)
|
|
| Cash from Investing Activities |
(90)
N/A
|
(104)
-16%
|
(106)
-2%
|
(73)
+31%
|
(86)
-18%
|
(77)
+11%
|
(93)
-21%
|
(67)
+27%
|
(51)
+25%
|
(47)
+7%
|
(4)
+91%
|
(81)
-1 785%
|
(73)
+9%
|
(89)
-21%
|
(96)
-8%
|
(62)
+35%
|
(249)
-300%
|
(286)
-15%
|
(348)
-22%
|
(240)
+31%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
91
|
22
|
1 486
|
1 485
|
1 485
|
0
|
0
|
100
|
100
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
19
|
|
| Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Other |
(0)
|
(2)
|
60
|
50
|
50
|
51
|
(11)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
90
N/A
|
20
-78%
|
1 545
+7 815%
|
1 534
-1%
|
1 533
0%
|
1 535
+0%
|
(13)
N/A
|
95
N/A
|
96
+0%
|
95
-1%
|
95
+0%
|
(3)
N/A
|
(3)
+1%
|
(2)
+36%
|
(2)
-8%
|
(2)
+20%
|
(1)
+37%
|
(1)
+12%
|
9
N/A
|
18
+88%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
1
|
1
|
1
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Net Change in Cash |
(184)
N/A
|
(253)
-37%
|
1 291
N/A
|
1 207
-7%
|
1 222
+1%
|
1 168
-4%
|
(420)
N/A
|
(223)
+47%
|
(277)
-24%
|
(249)
+10%
|
(251)
-1%
|
(380)
-51%
|
(371)
+2%
|
(396)
-7%
|
(433)
-9%
|
(384)
+11%
|
(532)
-39%
|
(524)
+1%
|
(505)
+4%
|
(393)
+22%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(264)
N/A
|
(262)
+1%
|
(218)
+17%
|
(310)
-42%
|
(264)
+15%
|
(314)
-19%
|
(345)
-10%
|
(304)
+12%
|
(391)
-28%
|
(369)
+6%
|
(405)
-10%
|
(336)
+17%
|
(322)
+4%
|
(347)
-8%
|
(387)
-12%
|
(382)
+1%
|
(345)
+10%
|
(274)
+21%
|
(187)
+32%
|
(179)
+5%
|
|